88
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Andrographolide suppresses thymic stromal lymphopoietin in phorbol myristate acetate/calcium ionophore A23187-activated mast cells and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like mice model

, , , , , , , , & show all
Pages 781-791 | Published online: 19 Feb 2016
 

Abstract

Background

Atopic dermatitis (AD) is one of the most common inflammatory cutaneous diseases. Thymic stromal lymphopoietin (TSLP) has been demonstrated to be an important immunologic factor in the pathogenesis of AD. The production of TSLP can be induced by a high level of intracellular calcium concentration and activation of the receptor-interacting protein 2/caspase-1/NF-κB pathway. Andrographolide (ANDRO), a natural bicyclic diterpenoid lactone, has been found to exert anti-inflammatory effects in gastrointestinal inflammatory disorders through suppressing the NF-κB pathway.

Objective

To explore the effect of ANDRO on the production of TSLP in human mast cells and AD mice model.

Methods

We utilized enzyme-linked immunosorbent assay, real-time reverse transcription polymerase chain reaction analysis, Western blot analysis, and immunofluorescence staining assay to investigate the effects of ANDRO on AD.

Results

ANDRO ameliorated the increase in the intracellular calcium, protein, and messenger RNA levels of TSLP induced by phorbol myristate acetate/calcium ionophore A23187, through the blocking of the receptor-interacting protein 2/caspase-1/NF-κB pathway in human mast cell line 1 cells. ANDRO, via oral or local administration, also attenuated clinical symptoms in 2,4-dinitrofluorobenzene-induced AD mice model and suppressed the levels of TSLP in lesional skin.

Conclusion

Taken together, ANDRO may be a potential therapeutic agent for AD through suppressing the expression of TSLP.

Acknowledgments

This work was supported by National Natural Science Foundation of China for the Youth (81201227), Science and Technology Commission of Shanghai Municipality (12411951600, 13XD1402900), and 2016 CMA-L’OREAL China Skin Grant (S2016131417). The funding sources had no role in the study design; collection, analysis, and interpretation of data; writing of the manuscript; and decision to submit the manuscript for publication.

Disclosure

The authors report no conflicts of interest in this work.